Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2016

01-06-2016 | Breast Oncology

Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?

Authors: Soo-Yeon Kim, MD, Eun-Kyung Kim, MD, PhD, Hye Sun Lee, MS, Min Jung Kim, MD, PhD, Jung Hyun Yoon, MD, PhD, Ja Seung Koo, MD, PhD, Hee Jung Moon, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2016

Login to get access

Abstract

Background

For asymptomatic benign papillomas detected at ultrasonography-guided 14-gauge core-needle biopsy (US–CNB), the decision to perform excision versus observation has been a topic of debate. We sought to determine which subgroup of asymptomatic benign papillomas without atypia diagnosed at US–CNB can be safely managed by observation versus immediate excision.

Materials

Overall, 230 asymptomatic benign papillomas in 197 women (mean age 46.6 ± 9.5 years; range 22–78), diagnosed at US–CNB using immunohistochemistry staining when needed and then managed by surgery (n = 144) or vacuum-assisted excision (VAE) with at least 12 months of follow-up after benign VAE results (n = 86) were included in this study. The upgrade rate to malignancy was calculated. Clinical and radiological variables, including age, size, Breast Image Reporting and Data System (BI–RADS) category, and imaging–pathology correlation were evaluated to find associations with malignancy using multivariate analysis.

Results

The upgrade rate to malignancy was 2.6 % (6 of 230): four were ductal carcinomas in situ and two were 1.5- and 9-mm-sized invasive ductal carcinomas without lymph node metastasis. The upgrade rates of papillomas with a BI–RADS category 3–4a and imaging–pathology concordance were 1.4 and 1.8 %, respectively. Category 4b–5 and imaging–pathology discordance were independently associated with malignancy, with upgrade rates of 13 and 50 %, respectively. Age and lesion size were not associated with malignancy.

Conclusion

Asymptomatic benign papillomas with probable benign or low suspicious US features or imaging–pathology concordance can be followed-up as opposed to immediate excision.
Literature
1.
Mulligan AM, O’Malley FP. Papillary lesions of the breast: a review. Adv Anat Pathol. 2007;14:108–19.CrossRefPubMed
2.
Ueng S-H, Mezzetti T, Tavassoli FA. Papillary neoplasms of the breast: a review. Arch Pathol Lab Med. 2009;133:893–907.PubMed
3.
Jaffer S, Nagi C, Bleiweiss IJ. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy. Cancer. 2009;115:2837–43.CrossRefPubMed
4.
Mcghan LJ, Pockaj BA, Wasif N, Giurescu ME, Mccullough AE, Gray RJ. Papillary lesions on core breast biopsy: excisional biopsy for all patients? Am Surg. 2013;79:1238–42.PubMed
5.
Moritani S, Ichihara S, Hasegawa M, et al. Uniqueness of ductal carcinoma in situ of the breast concurrent with papilloma: implications from a detailed topographical and histopathological study of 50 cases treated by mastectomy and wide local excision. Histopathology. 2013;63:407–17.CrossRefPubMed
6.
Bode M, Rissanen T, Apaja-Sarkkinen M. Ultrasonography-guided core needle biopsy in differential diagnosis of papillary breast tumors. Acta Radiol. 2009;50:722–9.CrossRefPubMed
7.
Ko ES, Cho N, Cha JH, Park JS, Kim SM, Moon WK. Sonographically-guided 14-gauge core needle biopsy for papillary lesions of the breast. Korean J Radiol. 2007;8:206–11.CrossRefPubMedPubMedCentral
8.
Tseng H, Chen Y, Chen S, et al. The management of papillary lesion of the breast by core needle biopsy. Eur J Surg Oncol. 2009;35:21–4.CrossRefPubMed
9.
Kil W-H, Cho EY, Kim JH, Nam S-J, Yang J-H. Is surgical excision necessary in benign papillary lesions initially diagnosed at core biopsy? Breast. 2008;17:258–62.CrossRefPubMed
10.
Shin HJ, Kim HH, Kim SM, et al. Papillary lesions of the breast diagnosed at percutaneous sonographically guided biopsy: comparison of sonographic features and biopsy methods. Am J Roentgenol. 2008;190:630–6.CrossRef
11.
Cheng T-Y, Chen C-M, Lee M-Y, et al. Risk factors associated with conversion from nonmalignant to malignant diagnosis after surgical excision of breast papillary lesions. Ann Surg Oncol. 2009;16:3375–9.CrossRefPubMed
12.
Youk JH, Kim E-K, Kwak JY, Son EJ. Atypical papilloma diagnosed by sonographically guided 14-gauge core needle biopsy of breast mass. Am J Roentgenol. 2010;194:1397–402.CrossRef
13.
Georgian-Smith D, Lawton TJ. Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective. Radiol Clin North Am. 2010;48:999–1012.CrossRefPubMed
14.
Ivan D, Selinko V, Sahin AA, Sneige N, Middleton LP. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy. Mod Pathol. 2004;17:165–71.CrossRefPubMed
15.
Youk JH, Kim E-K, Kwak JY, Son EJ, Park B-W, Kim S-I. Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy. Radiology. 2011;258:81–8.CrossRefPubMed
16.
Swapp RE, Glazebrook KN, Jones KN, et al. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013;20:1900–5.CrossRefPubMed
17.
Nakhlis F, Ahmadiyeh N, Lester S, Raza S, Lotfi P, Golshan M. Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol. 2015;22:1479–82.CrossRefPubMed
18.
Fu C-Y, Chen T-W, Hong Z-J, et al. Papillary breast lesions diagnosed by core biopsy require complete excision. Eur J Surg Oncol. 2012;38:1029–35.CrossRefPubMed
19.
Shouhed D, Amersi FF, Spurrier R, et al. Intraductal papillary lesions of the breast: clinical and pathological correlation. Am Surg. 2012;78:1161–5.PubMed
20.
Skandarajah AR, Field L, Mou AYL, et al. Benign papilloma on core biopsy requires surgical excision. Ann Surg Oncol. 2008;15:2272–7.CrossRefPubMed
21.
Rizzo M, Linebarger J, Lowe MC, et al. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. J Am Coll Surg. 2012;214:280–7.CrossRefPubMed
22.
Nakhlis F, Ahmadiyeh N, Lester S, Raza S, Lotfi P, Golshan M. Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol. 2015;22(5):1479–82.CrossRefPubMed
23.
Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol. 2004;122:440–3.CrossRefPubMed
24.
Ahmadiyeh N, Stoleru MA, Raza S, Lester SC, Golshan M. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol. 2009;16:2264–9.CrossRefPubMed
25.
Sakorafas G. Nipple discharge: current diagnostic and therapeutic approaches. Cancer Treat Rev. 2001;27:275–82.CrossRefPubMed
26.
Nayak A, Carkaci S, Gilcrease MZ, et al. Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. Clin Breast Cancer. 2013;13:439–49.CrossRefPubMedPubMedCentral
27.
Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151–63.CrossRefPubMedPubMedCentral
28.
Carder P, Garvican J, Haigh I, Liston J. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast. Histopathology. 2005;46:320–7.CrossRefPubMed
29.
Furuya C, Kawano H, Yamanouchi T, Oga A, Ueda J, Takahashi M. Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ. Pathol Int. 2012;62:381–90.CrossRefPubMed
30.
Grin A, O’Malley FP, Mulligan AM. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy. Am J Surg Pathol. 2009;33:1615–23.CrossRefPubMed
31.
Koo JS, Han K, Kim MJ, Moon HJ, Kim E-K, Park B-W. Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy? Breast Cancer Res Treat. 2013;137:797–806.CrossRefPubMed
32.
American College of Radiology. Breast imaging reporting and data system (BI-RADS). 4th ed. Reston: American College of Radiology; 2003.
33.
Salkowski LR, Fowler AM, Burnside ES, Sisney GA. Utility of 6-month follow-up imaging after a concordant benign breast biopsy result. Radiology. 2011;258:380–7.CrossRefPubMed
34.
Youk JH, Jung I, Kim E-K, et al. US follow-up protocol in concordant benign result after US-guided 14-gauge core needle breast biopsy. Breast Cancer Research Treat. 2012;132:1089–97.CrossRef
35.
Moon HJ, Jung I, Youk JH, Kim MJ, Kim E-K. Short-term follow-up in 6 months is unnecessary for asymptomatic breast lesions with benign concordant results obtained at ultrasonography-guided 14-gauge core needle biopsy. Am J Surg. 2016;211:152–8.CrossRefPubMed
36.
Kim MJ, Kim E-K, Kwak JY, et al. Nonmalignant papillary lesions of the breast at US-guided directional vacuum-assisted removal: a preliminary report. Eur Radiol. 2008;18:1774–83.CrossRefPubMed
37.
Youk JH, Kim MJ, Son EJ, Kwak JY, Kim E-K. US-guided vacuum-assisted percutaneous excision for management of benign papilloma without atypia diagnosed at US-guided 14-gauge core needle biopsy. Ann Surg Oncol. 2012;19:922–8.CrossRefPubMed
38.
Kalof A, Tam D, Beatty B, Cooper K. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol. 2004;57:625–9.CrossRefPubMedPubMedCentral
39.
40.
Youk JH, Kim E-K, Kim MJ, et al. Concordant or discordant? Imaging-pathology correlation in a sonography-guided core needle biopsy of a breast lesion. Korean J Radiol. 2011;12:232–40.CrossRefPubMedPubMedCentral
41.
SL Z, KY L. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–30.CrossRef
42.
Jung S-Y, Kang H-S, Kwon Y, et al. Risk factors for malignancy in benign papillomas of the breast on core needle biopsy. World J Surg. 2010;34:261–5.CrossRefPubMed
43.
Sakr R, Rouzier R, Salem C, et al. Risk of breast cancer associated with papilloma. Eur J Surg Oncol. 2008;34:1304–8.CrossRefPubMed
44.
Wen X, Cheng W. Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors. Ann Surg Oncol. 2013;20:94–101.CrossRefPubMed
45.
Hall FM. Screening mammography guidelines: an alternative proactive approach. Radiology. 2014;273:646–51.CrossRefPubMed
46.
Graf O, Helbich TH, Hopf G, Graf C, Sickles EA. Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy? Radiology. 2007;244:87–93.CrossRefPubMed
47.
Sickles EA. Probably benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol? Radiology. 1999;213:11–4.CrossRefPubMed
48.
Mercado CL, Hamele-Bena D, Oken SM, Singer CI, Cangiarella J. Papillary Lesions of the breast at percutaneous core-needle biopsy. Radiology. 2006;238:801–8.CrossRefPubMed
49.
Shah V, Flowers C, Douglas‐Jones A, Dallimore N, Rashid M. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens. Histopathology. 2006;48:683–91.CrossRefPubMed
Metadata
Title
Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?
Authors
Soo-Yeon Kim, MD
Eun-Kyung Kim, MD, PhD
Hye Sun Lee, MS
Min Jung Kim, MD, PhD
Jung Hyun Yoon, MD, PhD
Ja Seung Koo, MD, PhD
Hee Jung Moon, MD, PhD
Publication date
01-06-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 6/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5144-0

Other articles of this Issue 6/2016

Annals of Surgical Oncology 6/2016 Go to the issue

Breast Oncology

Intraoperative Radiation Therapy in Breast Cancer: Still Not Ready for Prime Time

Breast Oncology

Pilot Study of a New Nonradioactive Surgical Guidance Technology for Locating Nonpalpable Breast Lesions

Breast Oncology

Using Multilevel Models to Explain Variation in Clinical Practice: Surgeon Volume and the Surgical Treatment of Breast Cancer

Hepatobiliary Tumors

CD133 Expression at the Metastatic Site Predicts Patients’ Outcome in Colorectal Cancer with Synchronous Liver Metastasis

Thoracic Oncology

A Population-Based Cost Analysis of Thoracoscopic Versus Open Lobectomy in Primary Lung Cancer

Pancreatic Tumors

Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis